Basic Information
Basic information for AL158832.2-201-13aa
Peptide Name AL158832.2-201-13aa
Genome Position chr9:198236-198274[-]
Species Human
Peptide Sequence MVAHACNPSYSGG
Peptide Length 13
Unique No (AL645608.4-201-13aa,AL359551.1-201-13aa-1,AL645608.2-201-13aa,SOCS2-AS1-201-13aa-1,OIP5-AS1-201-13aa-4,SOCS2-AS1-202-13aa,LINC01299-201-13aa-2,LINC01220-201-13aa,LINC01228-201-13aa,AC104984.3-201-13aa-2,AC020917.4-201-13aa,AL031595.2-201-13aa-3,AC027097.2-202-13aa-1,SPART-AS1-204-13aa-1,AL139220.2-225-13aa-4,AC239860.4-201-13aa,ZNF790-AS1-207-13aa,AC069120.1-207-13aa,AC245427.2-201-13aa,SOCS2-AS1-206-13aa)
Grand Average of Hydropathicity 0.0154
Relative Molecular Mass 1509.62
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000287480;AL158832.2
Transcript ID/Name ENST00000657756;AL158832.2-201
Transcript Length 1613
Coding Ability 0.4687
DNA Sequence Corresponding to Peptide ATGGTGGCTCATGCCTGTAATCCAAGCTACTCGGGAGGC
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :